Skip to main content

Advertisement

Electronic cigarettes: towards evidence-based regulation

Series Editors: Dr Maciej L. Goniewicz and Tobacco Induced Diseases Editors-in-Chief Dr Constantine Vardavas and Dr James Elliott Scott.

Electronic cigarettes (e-cigarettes) are nicotine containing products that are sold for use as an alternative to cigarettes and may potentially reduce harm and the risk of tobacco-related diseases, particularly for those who are unable or unwilling to quit.

Regulating e-cigarettes creates unique challenges. The evaluation of the effect of e-cigarettes on public health require a wide range of evidence, including studies on the composition of a product, studies of human exposure, health effects, the likelihood of addiction and abuse, the perception and understanding of the product by the public, and the effect of marketing of the product. Furthermore, the effects of e-cigarettes not only on users of the product, but also on nonusers and on the population as a whole, need to be evaluated.

Regulation of e-cigarettes is a necessary precondition for assuring that the health of the public is protected. In many countries, national regulatory agencies have authority to regulate sale, distribution, labeling, and advertisement of nicotine containing products, and to set product standards. In the US, the Food and Drug Administration (FDA) has a broad authority to regulate the manufacturing and marketing of all tobacco products, including e-cigarettes. In the European Union, nicotine containing products currently do not fall under the Tobacco Products Directive (TPD), but in the on-going revision of the Directive different options regarding regulation of e-cigarettes are being evaluated.

For this thematic series in Tobacco Induced Diseases, we collect manuscripts which present the latest findings from several areas of interest including population use and risk perception of e-cigarettes, advertising, promotion, and marketing strategies, the abuse and addiction potential of the product, efficacy in smoking cessation, and an overview of what is known about the safety and efficacy of e-cigarettes.

Collection published in Tobacco Induced Diseases: 21 August 2014
Last updated: 27 June 2015

  1. Research

    Potential harmful health effects of inhaling nicotine-free shisha-pen vapor: a chemical risk assessment of the main components propylene glycol and glycerol

    A shisha-pen is an electronic cigarette variant that is advertised to mimic the taste of a water pipe, or shisha. The aim of this study was to assess the potential harmful health effects caused by inhaling the...

    Anne S Kienhuis, Lya G Soeteman-Hernandez, Peter MJ Bos, Hans WJM Cremers, Walther N Klerx and Reinskje Talhout

    Tobacco Induced Diseases 2015 13:15

    Published on: 27 June 2015

  2. Research

    Associations between perceptions of e-cigarette advertising and interest in product trial amongst US adult smokers and non-smokers: results from an internet-based pilot survey

    Electronic cigarettes (e-cigarettes) have risen in popularity in the U.S. While recent studies have described the prevalence and demographics of e-cigarette users, few studies have evaluated the impact of adve...

    Danielle M. Smith, Maansi Bansal-Travers, Richard J. O’Connor, Maciej L. Goniewicz and Andrew Hyland

    Tobacco Induced Diseases 2015 13:14

    Published on: 12 June 2015

  3. Research

    E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial

    People with mental illness have higher rates of smoking than the general population and are at greater risk of smoking-related death and disability. In smokers from the general population, electronic cigarette...

    Brigid O’Brien, Oliver Knight-West, Natalie Walker, Varsha Parag and Christopher Bullen

    Tobacco Induced Diseases 2015 13:5

    Published on: 24 March 2015

  4. Research

    Electronic cigarettes: overview of chemical composition and exposure estimation

    Electronic cigarettes (e-cigarettes) are advertised to tobacco users as a tool to decrease cigarette consumption and to reduce toxic exposure associated with conventional tobacco smoking. Little is known about...

    Jürgen Hahn, Yulia B Monakhova, Julia Hengen, Matthias Kohl-Himmelseher, Jörg Schüssler, Harald Hahn, Thomas Kuballa and Dirk W Lachenmeier

    Tobacco Induced Diseases 2014 12:23

    Published on: 9 December 2014

  5. Research

    Consumers’ perceptions of vape shops in Southern California: an analysis of online Yelp reviews

    E-cigarettes are sold at many different types of retail establishments. A new type of shop has emerged, the vape shop, which specializes in sales of varied types of e-cigarettes. Vape shops allow users to samp...

    Steve Sussman, Robert Garcia, Tess Boley Cruz, Lourdes Baezconde-Garbanati, Mary Ann Pentz and Jennifer B Unger

    Tobacco Induced Diseases 2014 12:22

    Published on: 28 November 2014

  6. Short report

    Challenges and priorities for E-cigarette regulation at the local level – insights from an Ontario tobacco control community-of-practice

    There has been minimal policy development in Canada to regulate when and where e-cigarettes can be used, and no policies to-date to set a minimum legal sale age to purchase e-cigarettes. Public Health professi...

    Ryan David Kennedy, Susan Himel, Irene Lambraki and Stephanie Filsinger

    Tobacco Induced Diseases 2014 12:18

    Published on: 28 October 2014

  7. Research

    E-cigarettes: online survey of UK smoking cessation practitioners

    Use of e-cigarettes (inhalable vapour producing battery powered devices that aim to simulate tobacco cigarettes), is rising in a number of countries, but as yet none of these products are regulated as medicina...

    Rosemary Hiscock, Maciej Lukasz Goniewicz, Andy McEwen, Susan Murray, Deborah Arnott, Martin Dockrell and Linda Bauld

    Tobacco Induced Diseases 2014 12:13

    Published on: 21 August 2014

Advertisement